Pédiatrie Tumeurs cérébrales MS100070-0087 Single-arm, Multicenter Phase I/Ib Study of Avelumab + Lenvatinib in Children With Primary CNS Tumors. Paris FRANCOIS DOZ
Appareil pulmonaire CHRYSALIS-2 (73841937NSC1001 ) An Open-label Phase 1/1b Study to Evaluate the Safety and Pharmacokinetics of JNJ-;73841937 (Lazertinib), a Third Generation EGFR-TKI, as Monotherapy or in;Combinations With JNJ-61186372, a Human Bispecific EGFR and cMet Antibody in;Participants With Advanced Non-Small Cell Lung Cancer Paris NICOLAS GIRARD
VADS TG4050.02 A randomized phase I trial in patients with newly-diagnosed, locoregionally advanced, HPV-negative, squamous cell carcinoma of the head and neck (SCCHN);evaluating a mutanome-directed immunotherapy;initiated at completion of primary treatment or at time of recurrence Paris CHRISTOPHE LE TOURNEAU
Sein Néoadjuvant EMBER-2 (J2J-MC-JZLB) EMBER-2: A Phase 1, Open-Label, Preoperative Window Study Evaluating the Biological Effects of LY3484356 in Post-menopausal Women With Stage I-III Estrogen Receptor-Positive, HER2-Negative Breast Cancer. Saint-Cloud FRANCOIS-CLEMENT BIDARD